Cybin Inc. to Present at Stifel Virtual Healthcare Conference

Ticker: HELP · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1833141

Sentiment: neutral

Topics: conference-participation, healthcare, psychedelics

TL;DR

Cybin presenting at Stifel virtual conference June 11, 2025. Psychedelic science update incoming.

AI Summary

Cybin Inc. announced on June 11, 2025, that it will participate in the Stifel 2025 Virtual Healthcare Conference. The company, headquartered at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9, will present its latest developments in psychedelic science and therapeutics.

Why It Matters

Participation in industry conferences allows Cybin to showcase its progress in psychedelic research and development to investors and the broader healthcare community.

Risk Assessment

Risk Level: low — This filing is a routine announcement of participation in a conference and does not contain material financial or operational changes.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K filing serves as a Report of Foreign Private Issuer, announcing Cybin Inc.'s participation in the Stifel 2025 Virtual Healthcare Conference.

When was this report filed?

This report was filed on June 11, 2025.

Who signed this report on behalf of Cybin Inc.?

Doug Drysdale, Chief Executive Officer, signed the report on behalf of Cybin Inc.

What is Cybin Inc.'s principal executive office address?

Cybin Inc.'s principal executive office is located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.

What is the SIC code for Cybin Inc.?

The Standard Industrial Classification (SIC) code for Cybin Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 by Doug Drysdale regarding CYBIN INC. (HELP).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing